Educational content only. Not medical advice. Consult a qualified physician.
Nicotinamide Adenine Dinucleotide peptide
Anti-AgingNAD+ is a well-characterized biological molecule. IV NAD+ therapy is offered clinically but not FDA-approved for specific disease indications. NMN and NR are sold as dietary supplements.

NAD+

Nicotinamide Adenine Dinucleotide

NAD+ is a coenzyme found in every cell, essential for energy metabolism, DNA repair, and cellular signaling. While not a peptide itself, NAD+ IV therapy and peptide-based NAD+ precursor protocols are commonly discussed alongside peptide therapies for longevity. NAD+ levels decline with age, and restoring them is a major focus of aging research.
Reported Benefits

Potential Benefits

  • Research confirms NAD+ is essential for mitochondrial energy production and DNA repair
  • Studies suggest declining NAD+ levels contribute to age-related metabolic dysfunction
  • Clinical and preclinical data indicate potential benefits from NAD+ repletion for energy and cognitive function
  • May support sirtuin enzyme activity, which is linked to longevity pathways
  • Research on precursors (NMN, NR) suggests improved biomarkers of aging in some studies
Research Dosing

Recommended Starting Dose

IV: 250 mg infused over 2-4 hours. Oral NMN: 250-500 mg daily. Oral NR: 300 mg daily.

Based on published research protocols. Not a prescription.

Dosing Protocol

IV protocols often involve 250-500 mg infused slowly (2-4 hours) daily for 3-5 consecutive days, followed by maintenance infusions monthly or as needed. Oral supplementation with precursors (NMN at 250-1000 mg/day or NR at 300-600 mg/day) is used for ongoing support. Sublingual and nasal formulations also exist.

DOSING INFORMATION DISCLAIMER: Any dosing information, protocols, or ranges discussed on this site are drawn from published research studies and clinical literature. They are presented for educational reference only and must not be used as self-medication guidance.

Research Timeline

Expected Timeline

Phase 1

IV NAD+ effects on energy and mental clarity are often reported within hours to days of infusion. Oral precursor supplementation may take 2-4 weeks for noticeable subjective effects. Biomarker changes may require longer assessment periods.

Regulatory

Research Status

NAD+ is a well-characterized biological molecule. IV NAD+ therapy is offered clinically but not FDA-approved for specific disease indications. NMN and NR are sold as dietary supplements.

The regulatory status of peptides can change at any time. Verify current FDA classification and legal status in your jurisdiction before seeking medical consultation about this compound.

Safety Profile

Potential Side Effects

  • IV NAD+ infusions commonly cause flushing, nausea, and chest tightness during administration
  • Cramping and discomfort during IV infusion (dose-rate dependent)
  • Oral precursors (NMN, NR) are generally well-tolerated but may cause mild GI symptoms
  • Theoretical concern about NAD+ supporting cancer cell metabolism (not confirmed clinically)
  • Cost of IV therapy is substantial
Related Research

More in Anti-Aging

Medical Disclaimer

EDUCATIONAL CONTENT ONLY: The peptide information presented on this page is compiled from published scientific literature, peer-reviewed research, and publicly available clinical data. It is provided strictly for educational purposes and does not constitute medical advice, an endorsement of any specific peptide, or a recommendation for treatment. Many peptides discussed on this site have not received FDA approval for human therapeutic use. Some may be under active regulatory review or subject to restrictions on compounding under FDA Section 503A and 503B frameworks. The regulatory status of individual peptides can change at any time. Readers should verify the current legal status of any peptide in their jurisdiction before pursuing further information or consultation. If you are considering peptide therapy, seek guidance from a licensed physician or healthcare provider who specializes in peptide-based treatments and operates within applicable federal and state regulations.